Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-024117
Filing Date
2021-02-16
Accepted
2021-02-16 16:30:39
Documents
2
Group Members
CALC IV LPCITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm214737d2_sc13ga.htm SC 13G/A 177401
2 EXHIBIT 99.1 tm214737d2_ex99-1.htm EX-99.1 18219
  Complete submission text file 0001104659-21-024117.txt   197353
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44055 | Film No.: 21639263
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A